Parrot David's Form 4 filing
Scribe Therapeutics, Inc. (SCTX) · filed Jul 27, 2026
- Accession no.
- 0002127908-26-000004
- Filed
- Jul 27, 2026, 9:20 PM ET
- Trade date
- Mar 13-Jul 23, 2026
- Filing delay
- 136 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 3 derivative transactions. Open-market purchases total $40.0K. It was filed 136 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Parrot DavidCIK 0002127908 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 23, 2026 | Common Stock | PPurchaseAcquired | +1,333 | $15.00 | +$19,995 | 1,333 | Indirect | |
| Jul 23, 2026 | Common Stock | PPurchaseAcquired | +1,333 | $15.00 | +$19,995 | 1,333 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 13, 2026 | Common Stock | AGrant or awardAcquired | +8,909 | $0.00 | $0 | 8,909 | Direct | |
| Jul 23, 2026 | Common Stock | AGrant or awardAcquired | +109,426 | $0.00 | $0 | 109,426 | Direct | |
| Jul 23, 2026 | Common Stock | AGrant or awardAcquired | +109,426 | $0.00 | $0 | 109,426 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.